Global Nicotinamide Mononucleotide (NMN) Competitive Landscape Professional Research Report 2024

Global Nicotinamide Mononucleotide (NMN) Competitive Landscape Professional Research Report 2024

Research Summary

Nicotinamide mononucleotide (NMN) is a molecule naturally found in the body and is a precursor to nicotinamide adenine dinucleotide (NAD+), a coenzyme essential for various biological processes. NMN is involved in cellular energy metabolism and plays a crucial role in maintaining cellular health and function. As we age, NAD+ levels in the body decline, which has been associated with various age-related health issues. NMN supplementation is believed to increase NAD+ levels, potentially offering benefits such as improved mitochondrial function, enhanced metabolism, and increased cellular repair. Research on NMN is ongoing, with studies exploring its potential effects on aging, longevity, and various age-related diseases. NMN supplements have gained popularity as a potential anti-aging intervention, although further research is needed to fully understand its effectiveness and safety.

According to DIResearch's in-depth investigation and research, the global Nicotinamide Mononucleotide (NMN) market size will reach XX US$ Million in 2024, and is expected to reach XX US$ Million in 2030, with a CAGR of XX% (2025-2030). Among them, the China market has changed rapidly in the past few years. The market size in 2024 will be XX US$ Million, accounting for approximately XX% of the world. It is expected to reach XX US$ Million in 2030, and the global share will reach XX%.

The major global manufacturers of Nicotinamide Mononucleotide (NMN) include GeneHarbor, Herbalmax, Genex Formulas, Shinkowa Pharmaceutical, Maac10 Formulas, EffePharm, Bontac, CELFULL, Kingdomway etc. The global players competition landscape in this report is divided into three tiers. The first tiers is the global leading enterprise, which occupies a major market share, is in a leading position in the industry, has strong competitiveness and influence, and has a large revenue scale; the second tiers has a certain share and popularity in the market, actively follows the industry leaders in product, service or technological innovation, and has a medium revenue scale; the third tiers has a smaller share in the market, has a lower brand awareness, mainly focuses on the local market, and has a relatively small revenue scale.

This report studies the market size, price trends and future development prospects of Nicotinamide Mononucleotide (NMN). Focus on analysing the market share, product portfolio, prices, sales volume, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global Nicotinamide Mononucleotide (NMN) market. The report data covers historical data from 2018 to 2023, based year in 2024 and forecast data from 2025 to 2030.

The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the Nicotinamide Mononucleotide (NMN) market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Nicotinamide Mononucleotide (NMN) industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.

The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.

Global Key Manufacturers of Nicotinamide Mononucleotide (NMN) Include:

GeneHarbor

Herbalmax

Genex Formulas

Shinkowa Pharmaceutical

Maac10 Formulas

EffePharm

Bontac

CELFULL

Kingdomway

Nicotinamide Mononucleotide (NMN) Product Segment Include:

Content Greater than or Equal to 98%

Content Less than 98%

Nicotinamide Mononucleotide (NMN) Product Application Include:

Health Care Products

Cosmetics

Others

Chapter Scope

Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends

Chapter 2: Global Nicotinamide Mononucleotide (NMN) Capacity and Production Analysis

Chapter 3: Global Nicotinamide Mononucleotide (NMN) Industry PESTEL Analysis

Chapter 4: Global Nicotinamide Mononucleotide (NMN) Industry Porter’s Five Forces Analysis

Chapter 5: Global Nicotinamide Mononucleotide (NMN) Major Regional Market Size (Revenue, Sales, Price) and Forecast Analysis

Chapter 6: Global Nicotinamide Mononucleotide (NMN) Market Size and Forecast by Type and Application Analysis

Chapter 7: North America Nicotinamide Mononucleotide (NMN) Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 8: Europe Nicotinamide Mononucleotide (NMN) Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 9: China Nicotinamide Mononucleotide (NMN) Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 10: APAC (Excl. China) Nicotinamide Mononucleotide (NMN) Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 11: Latin America Nicotinamide Mononucleotide (NMN) Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 12: Middle East and Africa Nicotinamide Mononucleotide (NMN) Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)

Chapter 13: Global Nicotinamide Mononucleotide (NMN) Competitive Analysis of Key Manufacturers (Sales, Revenue, Market Share, Price, Regional Distribution and Industry Concentration)

Chapter 14: Key Company Profiles (Product Portfolio, Sales, Revenue, Price and Gross Margin)

Chapter 15: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers

Chapter 16: Research Findings and Conclusion

Chapter 17: Methodology and Data Sources